Zobrazeno 1 - 10
of 36
pro vyhledávání: '"M. Yu. Drokov"'
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 132-141 (2023)
Since the middle of the last century, medical communities around the world have begun to attach great importance to the study of adherence to treatment in patients with diseases characterized by long-term and complex therapy, many complications and a
Externí odkaz:
https://doaj.org/article/c0c64e97ace149bc890df59dd2747c22
Publikováno v:
Трансплантология (Москва), Vol 14, Iss 4, Pp 488-499 (2022)
Allogeneic hematopoietic stem cells transplantation is one of the effective methods of treating patients with diseases of the blood system.Establishment of complete (100%) donor chimerism is among of the main indicators of successful transplantation
Externí odkaz:
https://doaj.org/article/90fcdb28c02c4b8f8fda00eee2198a27
Publikováno v:
Трансплантология (Москва), Vol 14, Iss 4, Pp 462-475 (2022)
The article has summarized the available data about regulatory T cells, describing in-detail the stages of their studying, their development, classification, mechanisms of immunosuppression in general terms and also in the context of allogeneic hemat
Externí odkaz:
https://doaj.org/article/f4dcf9d4700f465caf529661091c2508
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 0, Iss 5, Pp 94-105 (2022)
Introduction. Syngeneic hematopoietic stem cell transplantation is a type of allogeneic stem cell transplantation when the donor of stem cells is a genetically identical (monozygotic) twin of the recipient. After this type of transplantation, there i
Externí odkaz:
https://doaj.org/article/f04c0067b92046c29bf41b792da6c64b
Publikováno v:
Трансплантология (Москва), Vol 14, Iss 2, Pp 210-225 (2022)
Cytomegalovirus infection is one of the critical and life-threatening infectious complications in patients after allogeneic hematopoietic stem cell transplantation. The most significant risk factors for the development of cytomegalovirus infection ar
Externí odkaz:
https://doaj.org/article/cea8a815f5fe42699614e74de40dc650
Autor:
M. V. Demin, D. S. Tikhomirov, B. V. Biderman, M. Yu. Drokov, A. B. Sudarikov, T. A. Tupoleva, F. P. Filatov
Publikováno v:
Вопросы вирусологии, Vol 67, Iss 1, Pp 37-47 (2022)
Introduction. Infection caused by cytomegalovirus (CMV) is a serious problem for patients with weakened immunity, including patients with hematopoietic depression. The cases of complications associated with cytomegalovirus require antiviral therapy.
Externí odkaz:
https://doaj.org/article/beaff83fbe0b428cbe4f61a04e704992
Autor:
M. I. Akhmedov, G. A. Klyasova, E. N. Parovichnikova, L. A. Kuzmina, A. V. Fedorova, V. A. Vasil’eva, M. Yu. Drokov, S. M. Kulikov, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 17, Iss 1, Pp 121-134 (2022)
Background. Bloodstream infections (BSI) are common after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The objective of study was to analyze pre- and post-engraftment BSI.Materials and methods. From January 2018 till May 2021242 pa
Externí odkaz:
https://doaj.org/article/e6b1b47c70ec4a96b6e0418b270b5a19
Autor:
E. D. Mikhaltsova, N. N. Popova, M. Yu. Drokov, N. M. Kapranov, Yu. O. Davydova, V. A. Vasilieva, D. S. Dubnyak, U. V. Maslikova, I. V. Galtseva, L. A. Kuzmina, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Медицинская иммунология, Vol 23, Iss 5, Pp 1125-1136 (2021)
The graft-versus-host disease (GVHD) is among the most common complications after hematopoietic stem cell transplantation (allo-HSCT). The main tools for GVHD prevention remain calcineurin inhibitors (cyclosporin A, tacrolimus), methotrexate, mycophe
Externí odkaz:
https://doaj.org/article/d9f89a8ee79e4ad7b3bf668ee460f2a1
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 0, Iss 0 (2022)
Graft failure is a group of complications after allogeneic hematopoietic stem cell transplantation, which occurs according to different data up to 30%. The group of complications includes primary and secondary graft failure, primary, secondary and tr
Externí odkaz:
https://doaj.org/article/bf7aff1b0f8f44758c7bb04c548dc262
Autor:
L. A. Kuzmina, N. A. Petinati, V. A. Vasilieva, M. V. Dovydenko, M. Yu. Drokov, Yu. O. Davydova, N. M. Kapranov, N. V. Sats, Yu. A. Chabaeva, S. M. Kulikov, T. V. Gaponova, N. I. Drize, E. N. Parovichnikova, V. G. Savchenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 23-30 (2020)
Aim.Analysis of the effectiveness of the MSCs aministration as the second- or third-line therapy of acute GVHD (aGVHD) resistant to glucocorticosteroid treatment. Materials and methods.The study included 35 patients who received MSCs obtained from
Externí odkaz:
https://doaj.org/article/3fe1d38921b144ad954c53dba2f489ee